Search Articles:

Humira for ulcerative colitis - randomized to receive HUMIRA 160 mg at Week 0, 80 mg at Week 2, and 40 mg at Weeks 4 and 6 See Post

---

[] []male presented with [] abdominal pain for [] days. Associated nausea/vomiting. [] fever/chills. 
Choledocholithiasis - Risks and benefits of ERCP discussed with patient[] including bleeding, infection, perforation, pancreatitis, and death. Risk of pancreatitis stated as 15% for moderate pancreatitis and 1% for severe pancreatitis. Hand out describing procedure given to patient. Patient agreeable to proceed with ERCP. See Post

---

Five main types of choledochal cysts according to Todani classification, type I: ◦Ia: dilatation of extrahepatic bile duct (entire)
◦Ib: dilatation of extrahepatic bile duct (focal segment)
◦Ic: dilatation of the common bile duct portion of extrahepatic bile duct
•type II: true diverticulum from extrahepatic bile duct
•type III: dilatation of extrahepatic bile duct within the duodenal wall (choledochocoele)
•type IV: next most common◦IVa: cysts involving both intra and extrahepatic ducts
◦IVb: multiple dilatations/cysts of extrahepatic ducts only
•type V: multiple dilatations/cysts of intrahepatic ducts only (Caroli disease)
 See Post

---

Choledocholithiasis - epigastric abdominal pain, elevated liver enzymes, elevated bilirubin, abnormal MRI[]. Risks and benefits of ERCP discussed with patient[] including bleeding, infection, perforation, pancreatitis, and death. Risk of pancreatitis stated as 15% for moderate pancreatitis and 1% for severe pancreatitis. Patient agreeable to proceed with ERCP. See Post

---